DCOY

Decoy TherapeuticsD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Documents

Stored

Transcripts

Recent loaded

Latest report

2026-08-12

Investor release

Document history

Earnings documents stored for DCOY.

2 shown

Investor releaseQuarter not tagged2026-08-12

Decoy Therapeutics: Q2 Earnings Snapshot

Associated Press

Source

HOUSTON (AP) — HOUSTON (AP) — Decoy Therapeutics Inc. (DCOY) on Wednesday reported a loss of $2.4 million in its second quarter. On a per-share basis, the Houston-based company said it had a loss of $4.46. The biotech drug developer posted revenue of $228,000 in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DCOY at https://www.zacks.com/ap/DCOY

Investor releaseQuarter not tagged2026-05-09

Decoy Therapeutics: Q1 Earnings Snapshot

Associated Press

Source

HOUSTON (AP) — HOUSTON (AP) — Decoy Therapeutics Inc. (DCOY) on Friday reported a loss of $2.2 million in its first quarter. The Houston-based company said it had a loss of $4.18 per share. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DCOY at https://www.zacks.com/ap/DCOY

As of 2026-08-15 • Updated weeklySource: Earnings sourceIngestion runbook